novo nordisk glp-1 weight loss Nordisk's Oral Wegovy Approved by FDA | Maryam Daneshpour, PhD, MBA posted on the topic Novo asks FDA to prevent

Understanding How Your Digestive System Normally Functions To fully appreciate the impact of gastroparesis, it helps to understand how digestion typically works

As with all GLP-1 agonists, long-term post-marketing surveillance will be essential to characterize the pancreatic safety profile with greater statistical precision, particularly for rare events such as acute pancreatitis (estimated background rate of approximately 35 per 100,000 person-years in the general population) and the theoretical concern about pancreatic cancer

Recommended strategies to preserve lean mass during GLP-1 therapy include protein intake greater than 1.2 g/kg/day, evenly distributed across meals, combined with aerobic activity and structured resistance training

Real medication: Access semaglutide or tirzepatide, not herbal blends